Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Monica L. Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif T. Gjølberg, Timothy P. Jenkins, Bjørn Gunnar Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus R. Liedl, Peter M. Tessier, John McCafferty & Andreas H. Laustsen. (2023) Assessing developability early in the discovery process for novel biologics. mAbs 15:1.
Read now
Read now
Miroslav Dostalek, Thomayant Prueksaritanont & Robert F. Kelley. (2017) Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidates. mAbs 9:5, pages 756-766.
Read now
Read now
Barbara Zarzycka, Gerry A F Nicolaes & Esther Lutgens. (2015) Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis. Expert Review of Clinical Pharmacology 8:3, pages 297-313.
Read now
Read now
Emilie Duvallet, Luca Semerano, Eric Assier, Géraldine Falgarone & Marie-Christophe Boissier. (2011) Interleukin-23: A key cytokine in inflammatory diseases. Annals of Medicine 43:7, pages 503-511.
Read now
Read now
Charles J Malemud. (2010) Differential activation of JAK enzymes in rheumatoid arthritis and autoimmune disorders by pro-inflammatory cytokines: potential drug targets. International Journal of Interferon, Cytokine and Mediator Research 2, pages 97-111.
Read now
Read now
Articles from other publishers (30)
Heli A. Patel, Rishab R. Revankar, Sofia T. Pedroza, Shaveonte Graham & Steven R. Feldman. (2023) The Genetic Susceptibility to Psoriasis and the Relationship of Linked Genes to Our Treatment Options. International Journal of Molecular Sciences 24:15, pages 12310.
Crossref
Crossref
Torleif Tollefsrud Gjølberg, Rahel Frick, Simone Mester, Stian Foss, Algirdas Grevys, Lene Støkken Høydahl, Øystein Kalsnes Jørstad, Tilman Schlothauer, Inger Sandlie, Morten C. Moe & Jan Terje Andersen. (2022) Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life. Communications Biology 5:1.
Crossref
Crossref
Algirdas Grevys, Rahel Frick, Simone Mester, Karine Flem-Karlsen, Jeannette Nilsen, Stian Foss, Kine Marita Knudsen Sand, Thomas Emrich, Jens Andre Alexander Fischer, Victor Greiff, Inger Sandlie, Tilman Schlothauer & Jan Terje Andersen. (2022) Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life. iScience 25:2, pages 103746.
Crossref
Crossref
Sujata Pralhad Sawarkar & Vijay Yadav. (2021) Novel drug delivery strategies and gene therapy regimen as a promising perspective for management of psoriasis. Indian Journal of Dermatology, Venereology and Leprology 87, pages 333-340.
Crossref
Crossref
Bergithe E. Oftedal & Anette S. B. Wolff. (2020) New era of therapy for endocrine autoimmune disorders. Scandinavian Journal of Immunology 92:5.
Crossref
Crossref
Sruthi Vijaya Retnakumar & Sylviane Muller. (2019) Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases. Trends in Molecular Medicine 25:6, pages 516-537.
Crossref
Crossref
Stian Foss, Algirdas Grevys, Kine Marita Knudsen Sand, Malin Bern, Pat Blundell, Terje E. Michaelsen, Richard J. Pleass, Inger Sandlie & Jan Terje Andersen. (2016) Enhanced FcRn-dependent transepithelial delivery of IgG by Fc-engineering and polymerization. Journal of Controlled Release 223, pages 42-52.
Crossref
Crossref
Jonas Kügler, Sonja Wilke, Doris Meier, Florian Tomszak, André Frenzel, Thomas Schirrmann, Stefan Dübel, Henk Garritsen, Björn Hock, Lars Toleikis, Mark Schütte & Michael Hust. (2015) Generation and analysis of the improved human HAL9/10 antibody phage display libraries. BMC Biotechnology 15:1.
Crossref
Crossref
Doreen M. Floss, Jutta Schröder, Manuel Franke & Jürgen Scheller. (2015) Insights into IL-23 biology: From structure to function. Cytokine & Growth Factor Reviews 26:5, pages 569-578.
Crossref
Crossref
Jessica Jean, Marie Leroy, Alexandra Duque-Fernandez, Genevi?ve Bernard, Jacques Soucy & Roxane Pouliot. (2015) Characterization of a psoriatic skin model produced with involved or uninvolved cells. Journal of Tissue Engineering and Regenerative Medicine 9:7, pages 789-798.
Crossref
Crossref
Angela SchochHubert Kettenberger, Olaf Mundigl, Gerhard Winter, Julia Engert, Julia HeinrichThomas Emrich. (2015) Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics. Proceedings of the National Academy of Sciences 112:19, pages 5997-6002.
Crossref
Crossref
Tillie-Louise Hackett, Furquan Shaheen, Steven Zhou, Joanne L. Wright & Andrew Churg. (2014) Fibroblast Signal Transducer and Activator of Transcription 4 Drives Cigarette Smoke–Induced Airway Fibrosis. American Journal of Respiratory Cell and Molecular Biology 51:6, pages 830-839.
Crossref
Crossref
Christiane QuiniouMaria Domínguez-PunaroFrank CloutierAtefeh ErfaniJamila EnnaciriDurgajini SivanesanMélanie SanchezGaëlle ChognardXin HouJosé Carlos RiveraClaudine BeauchampGuy CharronMarie VilquinVijay Kuchroo, Stephen MichnickJohn D. Rioux, Sylvie LesageSylvain Chemtob. (2014) Specific targeting of the IL-23 receptor, using a novel small peptide noncompetitive antagonist, decreases the inflammatory response. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 307:10, pages R1216-R1230.
Crossref
Crossref
William Tausend, Christopher Downing & Stephen Tyring. (2014) Systematic Review of Interleukin-12, Interleukin-17, and Interleukin-23 Pathway Inhibitors for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis. Journal of Cutaneous Medicine and Surgery 18:3, pages 156-169.
Crossref
Crossref
Ricardo Prado Golmia, Ayk Helena Barbosa Martins & Morton Scheinberg. (2014) When anti-TNF fails, anti-IL12-23 is an alternate option in psoriasis and psoriatic arthritis. Revista Brasileira de Reumatologia (English Edition) 54:3, pages 247-249.
Crossref
Crossref
Ricardo Prado Golmia, Ayk Helena Barbosa Martins & Morton Scheinberg. (2014) Quando anti‐TNF não obtém sucesso, anti‐IL‐12‐23 é opção alternativa na psoríase e na artrite psoriásica. Revista Brasileira de Reumatologia 54:3, pages 247-249.
Crossref
Crossref
Anupam Mitra, Robyn S. Fallen & Hermenio Cavalcante Lima. (2012) Cytokine-Based Therapy in Psoriasis. Clinical Reviews in Allergy & Immunology 44:2, pages 173-182.
Crossref
Crossref
Jason J. Emer, Amir Larian & Mark G. Lebwohl. 2013. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy
319
332.e2
.
Franco Di Padova & Jose Carballido. 2013. IL-17, IL-22 and Their Producing Cells: Role in Inflammation and Autoimmunity. IL-17, IL-22 and Their Producing Cells: Role in Inflammation and Autoimmunity
333
347
.
W. Sterry & P. van de Kerkhof. (2012) Is ?class effect? relevant when assessing the benefit/risk profile of a biologic agent?. Journal of the European Academy of Dermatology and Venereology 26, pages 9-16.
Crossref
Crossref
Christopher E.M. Griffiths & Giampiero Girolomoni. (2012) Does p40-targeted therapy represent a significant evolution in the management of plaque psoriasis?. Journal of the European Academy of Dermatology and Venereology 26, pages 2-8.
Crossref
Crossref
Robyn S. Fallen, Collin R. Terpstra & Hermenio C. Lima. (2012) Immunotherapies in Dermatologic Disorders. Medical Clinics of North America 96:3, pages 565-582.
Crossref
Crossref
Pawel Traczewski & Lidia Rudnicka. (2012) Briakinumab for the Treatment of Plaque Psoriasis. BioDrugs 26:1, pages 9-20.
Crossref
Crossref
Frank Bachmann, Georgios Kokolakis, Wolfram Sterry & Sandra Philipp. (2011) Etanercept overview of clinical experience in the treatment of psoriasis and psoriatic arthritis. International Journal of Clinical Rheumatology 6:2, pages 135-155.
Crossref
Crossref
Brian P. Enright, Donna R. Davila, Belen M. Tornesi, Guenter Blaich, Alan M. Hoberman & Loretta A. Gallenberg. (2011) Developmental and reproductive toxicology studies in IL-12p40 knockout mice. Birth Defects Research Part B: Developmental and Reproductive Toxicology 92:2, pages 102-110.
Crossref
Crossref
Pauline L. Martin, Clifford Sachs, Noritaka Imai, Hideshi Tsusaki, Satoru Oneda, Qun Jiao & George Treacy. (2010) Development in the cynomolgus macaque following administration of ustekinumab, a human anti-il-12/23p40 monoclonal antibody, during pregnancy and lactation. Birth Defects Research Part B: Developmental and Reproductive Toxicology 89:5, pages 351-363.
Crossref
Crossref
J M Fletcher, S J Lalor, C M Sweeney, N Tubridy & K H G Mills. (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clinical and Experimental Immunology 162:1, pages 1-11.
Crossref
Crossref
JS Alexander, MK Harris, SR Wells, G. Mills, K. Chalamidas, VC Ganta, J. McGee, MH Jennings, E. Gonzalez-Toledo & A. Minagar. (2010) Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-β1b. Multiple Sclerosis Journal 16:7, pages 801-809.
Crossref
Crossref
Wolfgang Weger. (2010) Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents. British Journal of Pharmacology 160:4, pages 810-820.
Crossref
Crossref
Bernard Bizzini, Béatrice Drouet, Daniel Zagury, Marc Abitbol, Arsène Burny & Marie-Christophe Boissier. (2010) Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer. Immunotherapy 2:3, pages 347-365.
Crossref
Crossref